FDA Analysis of J&J's Single-Dose Covid-19 Vaccine Expected Today

FDA Analysis of J&J's Single-Dose Covid-19 Vaccine Expected Today

By The Wall Street Journal

A.M. Edition for Feb. 24. Today's release is a key step toward emergency authorization. WSJ's Jared Hopkins discusses the unusual alliances among drugmakers during the pandemic. WSJ's Mike Bird looks at the recent decline in the cryptocurrency market. Marc Stewart hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices
-
-
Heart UK
Mute/Un-mute